INOVIQ LTD — Director's Dealing 2019

Sep 30, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	BARD1 LIFE SCIENCES LIMITED
ABN	58 009 070 384

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	IRMGARD IRMINGER-FINGER
Date of last notice	15 July 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsiblNote: In the case of a company, interests which come within paragraph (i) of the definition of “notidisclosed in this part.Direct or indirect interestDIRECTNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Date of chane1 October 2019	In the case of a trust, this includes interests in the trust made available by the responsiblNote: In the case of a company, interests which come within paragraph (i) of the definition of “notidisclosed in this part.Direct or indirect interestDIRECTNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Date of chane1 October 2019	In the case of a trust, this includes interests in the trust made available by the responsiblNote: In the case of a company, interests which come within paragraph (i) of the definition of “notidisclosed in this part.Direct or indirect interestDIRECTNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Date of chane1 October 2019	e entity of the trustfiable interest of a director” should be	e entity of the trustfiable interest of a director” should be
	Direct or indirect interest	DIRECT
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
	Date of chane	1 October 2019
	g
	No. of securities held prior to change	112,652,737 Ordinary Shares108,252,420 Performance Shares with an expirydate of5 yearsfromdate of issue
	Class	Ordinary Shares
	Number acquired	9,999,600
	Number disposed	Nil
	Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	Nil (beneficiary of deceased estate)
	No. of securities held after change	122,652,337 Ordinary Shares108,252,420 Performance Shares with an expirydate of 5 years from date of issue

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback

Dr Irminger-Finger received the shares as beneficiary of a deceased estate

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	N/A
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

Dated: 01 October 2019

• See chapter 19 for defined terms.

Appendix 3Y Page 2